FUJIFILM Diosynth Biotechnologies Denmark ApS
CVR number: 26060702
Biotek Allé 1, 3400 Hillerød
tel: 77416070
Income statement (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 2 039.47 | 2 727.43 | 3 068.98 | 3 450.90 | 4 303.00 |
| Costs of manufacturing | -2 446.04 | -3 041.98 | |||
| Gross profit | 65.12 | 494.44 | 561.26 | 1 004.86 | 1 261.02 |
| Costs of management | - 345.43 | - 392.96 | |||
| Other operating expenses | -0.02 | ||||
| Total depreciation | - 488.70 | - 411.38 | |||
| EBIT | 65.12 | 494.44 | 561.26 | 659.43 | 868.04 |
| Other financial income | 130.40 | 72.27 | |||
| Other financial expenses | - 188.21 | - 407.51 | |||
| Pre-tax profit | - 176.32 | 103.55 | 213.46 | 601.62 | 532.79 |
| Income taxes | - 131.30 | - 132.56 | |||
| Net earnings | - 176.32 | 103.55 | 213.46 | 470.32 | 400.24 |
Assets (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 181.28 | 272.33 | |||
| Intangible rights | 122.47 | 89.33 | |||
| Goodwill | 45.80 | ||||
| Intangible assets total | 349.54 | 361.66 | |||
| Land and waters | 1 556.36 | 1 436.33 | |||
| Buildings | 23.30 | 16.80 | |||
| Machinery and equipment | 1 269.56 | 1 158.43 | |||
| Advance payments and construction in progress | 7 074.41 | 12 736.77 | |||
| Tangible assets total | 9 923.63 | 15 348.34 | |||
| Other receivables | 5 495.14 | 5 848.43 | 8 455.62 | ||
| Investments total | 5 495.14 | 5 848.43 | 8 455.62 | ||
| Long term receivables total | |||||
| Semifinished products | 65.04 | 57.83 | |||
| Raw materials and consumables | 1 064.78 | 1 130.69 | |||
| Inventories total | 1 129.82 | 1 188.52 | |||
| Current trade debtors | 315.92 | 926.20 | |||
| Current amounts owed by group member comp. | 37.13 | 48.41 | |||
| Prepayments and accrued income | 26.85 | 30.84 | |||
| Current other receivables | 1 760.51 | 1 696.18 | |||
| Short term receivables total | 2 140.41 | 2 701.63 | |||
| Cash and bank deposits | 140.26 | 901.24 | |||
| Cash and cash equivalents | 140.26 | 901.24 | |||
| Balance sheet total (assets) | 5 495.14 | 5 848.43 | 8 455.62 | 13 683.66 | 20 501.39 |
Equity and liabilities (mDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 3 761.87 | 3 865.42 | 4 078.88 | 0.39 | 0.39 |
| Retained earnings | 176.32 | - 103.55 | - 213.46 | 4 078.49 | 4 548.81 |
| Profit of the financial year | - 176.32 | 103.55 | 213.46 | 470.32 | 400.24 |
| Shareholders equity total | 3 761.87 | 3 865.42 | 4 078.88 | 4 549.20 | 4 949.44 |
| Provisions | 255.34 | 260.03 | |||
| Non-current advances received | 137.66 | 151.56 | |||
| Non-current owed to group member | 12 166.29 | ||||
| Non-current liabilities total | 137.66 | 12 317.86 | |||
| Current loans from credit institutions | 415.74 | ||||
| Advances received | 449.47 | 464.86 | |||
| Current trade creditors | 1 820.93 | 1 672.72 | |||
| Current owed to group member | 6 246.85 | 96.62 | |||
| Short-term deferred tax liabilities | 6.12 | 57.59 | |||
| Other non-interest bearing current liabilities | 218.09 | 266.54 | |||
| Current liabilities total | 8 741.45 | 2 974.07 | |||
| Balance sheet total (liabilities) | 3 761.87 | 3 865.42 | 4 078.88 | 13 683.66 | 20 501.39 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.